Compare Garrett Motion Inc. Common Stock (GTX) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Garrett Motion Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Garrett Motion Inc. Common Stock trades at $26.25 (market cap $4.80B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.6× Garrett Motion Inc. Common Stock's market cap, and Garrett Motion Inc. Common Stock pays a 1.24% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Garrett Motion Inc. Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GTX | HALO | |
|---|---|---|
Market Cap | $4.80B | $12.58B |
Volume | 2,132,039 | 2,179,278 |
Sector | Consumer Cyclical | Health |
52-Week High | $36.23 | $115.22 |
52-Week Low | $12.49 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $6.06B | $14.49B |
Dividend Yield | 1.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Garrett Motion Inc. Common Stock
Garrett Motion develops turbocharging and air-boosting technologies for vehicles. Its products are used in internal combustion, hybrid, and other vehicle powertrains.
Read more on GTX →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
